These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 47105)

  • 1. Letter: Thromboembolism, oral contraceptives, and oestrogen concentration gradient.
    Mueller H; Stadel BV
    Lancet; 1975 Mar; 1(7908):683-4. PubMed ID: 47105
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contraceptives and thromboembolism (author's transl)].
    Sato K; Ogino M; Nakabayashi M; Sakamoto S
    Kokyu To Junkan; 1978 Mar; 26(3):212-20. PubMed ID: 349637
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipid metabolism disorders and increased vascular risk due to contraceptive steroids].
    Basdevant A; de Lignieres B; Mauvais-Jarvis P
    Nouv Presse Med; 1976 Apr; 6(17):1469-72. PubMed ID: 1025526
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen and thromboembolic problems.
    Shiffman MA
    Plast Reconstr Surg; 2002 Aug; 110(2):713-5. PubMed ID: 12142713
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing oral contraception.
    Read MD
    Practitioner; 1980 Feb; 224(1340):179-81. PubMed ID: 7367372
    [No Abstract]   [Full Text] [Related]  

  • 7. Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives.
    Nissen ED; Kent DR; Nissen SE
    Am J Obstet Gynecol; 1977 Jan; 127(1):61-6. PubMed ID: 188339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content.
    Böttiger LE; Boman G; Eklund G; Westerholm B
    Lancet; 1980 May; 1(8178):1097-101. PubMed ID: 6103437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contraception and arterial hypertension].
    Corvol P; Millet D; Keledjian P
    Acquis Med Recent; 1977; ():177-80. PubMed ID: 910596
    [No Abstract]   [Full Text] [Related]  

  • 10. Concomitant estrogen use has been alleged to increase the side effects of certain oxidatively-metabolized psychiatric drugs. Are there any estrogen-free oral contraceptives (OCs)?
    Shader RI
    J Clin Psychopharmacol; 1989 Jun; 9(3):233. PubMed ID: 2738190
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical dosages for oral contraceptives.
    Mladenović D; Grcić R; Pestelek B; Kapor M
    J Int Med Res; 1977; 5(4):276-80. PubMed ID: 881099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Prenatal sex-hormone exposure and congenital limb-reduction defects.
    Lancet; 1976 Aug; 2(7981):372-3. PubMed ID: 60606
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral contraceptives: mechanisms in thromboembolism.
    Lancet; 1980 May; 1(8178):1118-9. PubMed ID: 6103446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents].
    Gambini G; Farina G; Arbosti G
    Med Lav; 1976; 67(2):152-7. PubMed ID: 1021708
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possible interference of synthetic estroprogestins with thyroid hormone production].
    Paggi A; Leri O; Evangelista M; Manfredi F; Coarelli C; Loiacono C; Cassone R
    Clin Ter; 1981 Aug; 98(4):349-63. PubMed ID: 7285541
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral contraceptives and vascular thrombosis.
    Andrews WC
    South Med J; 1977 May; 70(5):519-20. PubMed ID: 323987
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estrogen/progestogen-exposure and fetal effects].
    Forsberg JG
    Tidsskr Nor Laegeforen; 1977 Oct; 97(30):1583-4. PubMed ID: 929540
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: Oral contraceptives and liver tumours.
    Lancet; 1975 Jun; 1(7922):1414-5. PubMed ID: 49570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Syndrome of hyperinhibition of the gonadotropic function of the pituitary gland].
    Smetnik VP
    Akush Ginekol (Mosk); 1977 Jul; (7):1-4. PubMed ID: 561554
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of contraceptive methods: amenorrhea.
    Hanson FW
    J Reprod Med; 1975 Oct; 15(4):153-7. PubMed ID: 1214257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.